The global Clinical Trial Supply Services market was valued at US$ 2076.4 million in 2022 and is projected to reach US$ 3545.5 million by 2029, at a CAGR of 7.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Clinical Trial Supply Services market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Clinical Trial Supply Services market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Clinical Trial Supply Services market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and available infrastructures.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Supply Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Supply Services. This report contains market size and forecasts of Clinical Trial Supply Services in global, including the following market information:
- Global Clinical Trial Supply Services Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
Safe clinical trials are premised on strong supply chain management of the investigational drug, in accordance with regional and global regulations, and in line with local production and development realities. Clinical trial consumable management is critical to avoid overproduction, inventory expiration, and oversupply.As the cost of drug development continues to rise, the supply of clinical trials is becoming ever more important.In addition, strict operational requirements for the implementation of a variety of biopharmaceutical products into clinical trials require constant reform of clinical trial supply strategies.This also requires the integration of multiple third party vendors at all stages of clinical development. Global Clinical Trial Supplies key players include Thermo Fisher Scientific, Catalent Pharma Solutions, Almac Group, Parexel International, UDG Healthcare etc. China top five manufacturers hold a Production Share over 70%. North America accounts for the most Sales Market Share, which have a share over 50%, followed by Europe. In terms of product, Supply Chain Management is the largest segment, with a Market Share over 35%. And in terms of application, the largest Application is Clinical Phase iii.
We surveyed the Clinical Trial Supply Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Trial Supply Services Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Clinical Trial Supply Services Market Segment Percentages, by Type, 2022 (%)
- Manufacturing
- Packaging and Labeling
- Logistics and Distribution
Global Clinical Trial Supply Services Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Clinical Trial Supply Services Market Segment Percentages, by Application, 2022 (%)
- Oncology
- Cardiovascular Diseases
- Respiratory Diseases
- CNS And Mental Disorders
- Dermatology
- Blood Disorders
- Infectious Diseases
- Others
Global Clinical Trial Supply Services Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Clinical Trial Supply Services Market Segment Percentages, By Region and Country, 2022 (%)
-
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
The Middle East and Africa (Middle East, Africa)
South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Clinical Trial Supply Services revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Clinical Trial Supply Services revenues share in global market, 2022 (%)
key players include:
- Parexel International
- ALMAC Group
- Catalent Pharma Solutions
- Piramal Pharma Solutions
- Shertech Manufacturing
- Thermo Fisher Scientific
- PCI Services
- Patheon, Inc.
- Sharp Packaging Services
- Biocair
- Movianto
- Klifo A/S.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Clinical Trial Supply Services, market overview.
Chapter 2: Global Clinical Trial Supply Services market size in revenue.
Chapter 3: Detailed analysis of Clinical Trial Supply Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clinical Trial Supply Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
